Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose vs Low-Dose Caffeine Citrate in Apnea of Prematurity
NCT06905496Phase 1Active, not recruiting
- Sponsor
- Nishtar Medical University
- Start
- Jun 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of caffeine in apnea of prematurity (AOP) (2 arms), sponsored by Nishtar Medical University. Primary endpoint: Enhanced Respiratory Stimulation. Started Jun 2024; status: active, not recruiting.
02
Drugs
caffeine
03
Conditions
apnea of prematurity (AOP)
Beyond the preview
Go deeper on NCT06905496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06905496.